Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza matrix protein 1 (M1) is the most abundant structural protein in influenza A virions. It forms a continuous layer beneath the viral lipid envelope, acting as an endoskeleton that is essential for multiple stages of the virus life cycle, including assembly, budding, disassembly during entry into new host cells, and regulation of viral ribonucleoprotein (vRNP) trafficking.
Disruption of M1 function leads to impaired viral assembly and budding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza Matrix Protein 1 (M1).